The recommended starting and target dose for ABILIFY is 10 or 15 mg/day administered on a once-a-day schedule without regard to meals. ABILIFY has been systematically evaluated and shown to be effective in a dose range of 10 to 30 mg/day, when administered as the tablet formulation; howeve...
The recommended starting and target dose for ABILIFY is 10 or 15 mg/day administered on a once-a-day schedule without regard to meals. ABILIFY has been systematically evaluated and shown to be effective in a dose range of 10 to 30 mg/day, when administered as the tablet formulation; howeve...
CYP2D6 AND CYP3A4 inhibitors: 160 mg IM CYP3A4 inducers: Avoid use Dosage Modifications (Aristada) No dosage changes if CYP450 modulators are added for <2 wk Strong CYP3A4 inhibitor for >2 wk Reduce the dose to the next lower strength No dosage adjustment necessary in patients taking 441...
Famotidine:Coadministration of aripiprazole (given in a single dose of 15 mg) with a 40-mg single dose of the H2antagonist famotidine, a potent gastric acid blocker, decreased the solubility of aripiprazole and, hence, its rate of absorption, reducing by 37% and 21% the Cmaxof aripiprazole ...
ABILIFY MAINTENA is only to be administered by intramuscular injection by a healthcare professional. The recommended starting and maintenance dose of ABILIFY MAINTENA is 400 mg monthly (no sooner than 26 days after the previous injection).
The recommended dose of Abilify MyCite depends on the condition being treated and ranges from 5 to 15 mg/day. What Drugs, Substances, or Supplements Interact with Abilify MyCite? Abilify MyCite may interact with: itraconazole, clarithromycin, ...
The recommended starting and target dose for ABILIFY is 10 or 15 mg/day administered on a once-a-day schedule without regard to meals. ABILIFY has been systematically evaluated and shown to be effective in a dose range of 10 to 30 mg/day, when administered as the tablet formulation; howeve...